Follow-The-Filings

Security · featured owners

JBIO Jade Biosciences Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 6.1%
  • $41M
  • 1 add 1 reduce

JBIO (Jade Biosciences Inc.) is held in 2 featured 13F books as of 2026 Q2. David Witzke - Avidity Partners Management is the largest tracked holder by portfolio weight (6.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 6.1% (David Witzke - Avidity Partners Management) · not free-float ownership

  1. David Witzke add 6.1%
  2. James Silverman reduce 0.29%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 6.1% Add +21.4% 1,700,708 $38M history
James Silverman - Opaleye Management 2026 Q2 0.29% Reduce −66.1% 145,000 $3M history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$75.52M -$69.63M -$127.41M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.23M $80.12M $348.82M
Total non-current assets * $3.19M $0.215M $0.965M
Total assets $127.42M $80.33M $349.78M
Total current liabilities $17.64M $3.83M $16.54M
Total non-current liabilities * $325,000 $70,000 $724,000
Total equity $109.46M $76.43M $332.52M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$56.78M -$71.2M -$94.69M
Cash from investing $11.88M $56.03M -$247.01M
Cash from financing $46M $25.43M $360.77M
Net change in cash $1.09M $10.26M $19.05M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders